Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Palisade Bio (PALI) Accumulated Depreciation & Amortization (2016 - 2020)

Palisade Bio has reported Accumulated Depreciation & Amortization over the past 10 years, most recently at $910956.0 for Q4 2020.

  • Quarterly Accumulated Depreciation & Amortization fell 4.15% to $910956.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $910956.0 through Dec 2020, down 4.15% year-over-year, with the annual reading at $910956.0 for FY2020, 4.15% down from the prior year.
  • Accumulated Depreciation & Amortization was $910956.0 for Q4 2020 at Palisade Bio, down from $950417.0 in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $950417.0 in Q4 2019 and troughed at $724771.0 in Q4 2016.
  • The 5-year median for Accumulated Depreciation & Amortization is $902260.0 (2018), against an average of $862065.8.
  • Year-over-year, Accumulated Depreciation & Amortization rose 15.31% in 2016 and then decreased 4.15% in 2020.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $724771.0 in 2016, then grew by 13.4% to $821925.0 in 2017, then rose by 9.77% to $902260.0 in 2018, then rose by 5.34% to $950417.0 in 2019, then decreased by 4.15% to $910956.0 in 2020.
  • Per Business Quant, the three most recent readings for PALI's Accumulated Depreciation & Amortization are $910956.0 (Q4 2020), $950417.0 (Q4 2019), and $902260.0 (Q4 2018).